Free Trial

Barclays PLC Buys 41,301 Shares of Cadre Holdings, Inc. (NYSE:CDRE)

Cadre logo with Industrials background

Barclays PLC grew its holdings in Cadre Holdings, Inc. (NYSE:CDRE - Free Report) by 77.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,698 shares of the company's stock after acquiring an additional 41,301 shares during the quarter. Barclays PLC owned 0.23% of Cadre worth $3,059,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. WCM Investment Management LLC bought a new stake in shares of Cadre during the fourth quarter valued at approximately $12,420,000. Raymond James Financial Inc. bought a new stake in Cadre in the 4th quarter valued at $8,179,000. Catawba River Capital raised its stake in shares of Cadre by 51.5% in the 4th quarter. Catawba River Capital now owns 455,824 shares of the company's stock valued at $14,723,000 after buying an additional 154,986 shares in the last quarter. Loomis Sayles & Co. L P lifted its holdings in shares of Cadre by 11.3% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,047,097 shares of the company's stock worth $33,821,000 after acquiring an additional 106,366 shares during the period. Finally, Brown University acquired a new stake in shares of Cadre during the 4th quarter valued at about $3,256,000. Institutional investors and hedge funds own 43.95% of the company's stock.

Cadre Price Performance

NYSE:CDRE traded down $0.01 during mid-day trading on Friday, hitting $29.66. The company's stock had a trading volume of 339,834 shares, compared to its average volume of 246,215. The company has a current ratio of 3.01, a quick ratio of 1.96 and a debt-to-equity ratio of 0.65. The stock has a fifty day moving average of $31.05 and a 200-day moving average of $33.74. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of 35.73, a P/E/G ratio of 1.58 and a beta of 1.33. Cadre Holdings, Inc. has a fifty-two week low of $27.07 and a fifty-two week high of $40.28.

Cadre (NYSE:CDRE - Get Free Report) last posted its earnings results on Tuesday, March 11th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.48 by ($0.16). Cadre had a return on equity of 12.88% and a net margin of 6.34%. The company had revenue of $175.98 million for the quarter, compared to the consensus estimate of $170.95 million. During the same quarter last year, the business earned $0.25 EPS. Cadre's quarterly revenue was up 41.3% compared to the same quarter last year. As a group, equities analysts forecast that Cadre Holdings, Inc. will post 1.05 EPS for the current fiscal year.

Cadre Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 16th. Shareholders of record on Friday, May 2nd will be given a $0.095 dividend. The ex-dividend date of this dividend is Friday, May 2nd. This represents a $0.38 dividend on an annualized basis and a yield of 1.28%. Cadre's dividend payout ratio (DPR) is presently 42.22%.

Insider Activity

In related news, CEO Warren B. Kanders sold 50,000 shares of the firm's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $31.88, for a total transaction of $1,594,000.00. Following the completion of the sale, the chief executive officer now directly owns 10,866,192 shares of the company's stock, valued at $346,414,200.96. This trade represents a 0.46 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 37.00% of the stock is currently owned by corporate insiders.

About Cadre

(Free Report)

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.

Recommended Stories

Institutional Ownership by Quarter for Cadre (NYSE:CDRE)

Should You Invest $1,000 in Cadre Right Now?

Before you consider Cadre, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.

While Cadre currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines